Urinary incontinence affects a significant proportion of spayed female dogs and can cause skin problems, secondary infection, and owner frustration that threatens the human-animal bond. Effective treatments exist and transform welfare.
Urinary incontinence welfare involves both the physical consequences of leakage and the threat to the human-animal bond from frustrated owners. Dogs are typically unaware of their incontinence — they do not choose to urinate inappropriately. Skin scalding from chronic urine contact causes discomfort and secondary bacterial pyoderma requiring treatment. Owner distress and cleaning burden sometimes leads to relinquishment decisions for what is a highly manageable condition. PPA (phenylpropanolamine) improves urethral sphincter tone effectively in the majority of affected dogs and is well-tolerated for long-term use. Oestrogen supplementation (oestriol) is an alternative with similarly good efficacy. Managing secondary skin changes with barrier creams and regular washing reduces welfare impact while medication takes effect. Owner education that incontinence is a medical condition, not behavioural, is critical for maintaining the human-animal relationship and preventing inappropriate euthanasia or relinquishment.